The Glaucoma Foundation Expands Board of Directors
The Glaucoma FoundationTwo prominent ophthalmologists join the TGF Board.
Two prominent ophthalmologists join the TGF Board.
The U.S. Food and Administration (FDA) last week qualified the American Academy of Ophthalmology’s patient-reported outcome measure for premium intraocular lenses (IOLs) as a Medical Device Development Tool (MDDT).
This month, SriniVas R. Sadda, MD, FARVO, was welcomed as the new 2024 – 2025 president for the Association for Research in Vision and Ophthalmology (ARVO) at its Annual Meeting held recently in Seattle, Wash.
In what they believe is a solution to a 30-year biological mystery, neuroscientists at Johns Hopkins Medicine say they have used genetically engineered mice to address how one mutation in the gene for the light-sensing protein rhodopsin results in congenital stationary night blindness.
The American Macular Degeneration Foundation supports a diverse portfolio of research investigations to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD.
Judy and Charles Munnerlyn, PhD, were honored to recognize their extraordinary contributions to improving vision for people around the world.
The Truhlsen-Marmor Museum of the Eye® today announced the opening of Hoodwinked: 19th Century Quack Medicine.
Fu-Shin Yu, Ph.D., professor of ophthalmology, visual and anatomical sciences in the Wayne State University School of Medicine, received an award from the National Eye Institute of the National Institutes of Health for his study aiming to reverse the adverse effects of diabetes on eyesight.
Research to Prevent Blindness is pleased to announce that it has opened a new round of grant funding for high-impact vision research, including research related to glaucoma, age-related macular degeneration, inherited retinal diseases, myopia, amblyopia, low vision and many more.
A new approach to gene therapy resets cell homeostasis. Clinical trials to treat the retinal disorders Retinitis Pigmentosa, Stargardt's, and Geographic Atrophy (late dry macular degeneration) are underway and showing promise.
New study led by Univ. of Leicester & Cooper Medical School of Rowan Univ. finds early patching improves treatment for childhood 'lazy eye' (amblyopia). Published in Lancet. Optimizing care for young patients.
Healthy sight allows us to see all of the world’s wonders, and healthy retinas make healthy sight possible. When retinal disease strikes and a clear view of the world is replaced by a curtain-like shadow, central blurriness, or straight lines that appear wavy, it’s critical to seek out the expert care uniquely provided by a retina specialist.
Regener-Eyes® LLC, a leading name in the ophthalmic industry, is registered, regulated, inspected and in full compliance with all FDA regulations. Regener-Eyes® is dedicated to safety, quality, and compliance.
The prestigious group brings together key industry leaders and members of the corporate community dedicated to glaucoma patient care.
The American Society of Retina Specialists (ASRS) invites members of the press to cover the latest advances in retina science and practice during its 42nd Annual Scientific Meeting July 17-20, 2024.
An eye movement study led by a New York Institute of Technology psychology researcher suggests that techniques used in a Baroque-era painting could help today’s marketers catch the attention of modern consumers.
As people prepare to thrill at the phenomenon of the eclipse today, Lauren Lusardi, OD, FAAO, an optometrist with Atlantic Health System in New Jersey, breaks down how the event makes us susceptible to eye damage and useful tips on how to protect yourself.
The April 8 solar eclipse—a spectacular show in the sky when the moon will pass in front of the sun—is almost here. University of Miami ophthalmologists explain how to view it safely.